C-reactive protein in chronic heart failure: A new predictor of survival

International Journal of Cardiology

Volumn 135, Issue 3, 2009, Pages 396-397

  Celik, Turgay ^a   Iyisoy, Atila ^a   Celik, Murat ^a   Yuksel, U Cagdas ^b   Kardesoglu, Ejder ^c  

^a GULHANE SCHOOL OF MEDICINE   (Turkey)

^b Sarikamis Army District Hospital Turkey   (Turkey)

^c GATA HAYDARPASA TRAINING HOSPITAL   (Turkey)

Author keywords

C reactive protein; Heart failure; Prognosis

Indexed keywords

C REACTIVE PROTEIN;

ARTICLE; CARDIOVASCULAR DISEASE; DIASTOLIC HEART FAILURE; DISEASE SEVERITY; HEART FAILURE; HUMAN; IMMUNOSTIMULATION; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; SURVIVAL; SYSTOLIC HEART FAILURE;

BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CHRONIC DISEASE; HEART FAILURE; HUMANS; PREDICTIVE VALUE OF TESTS; SURVIVAL RATE;

EID: 67349117825     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2007.12.116     Document Type: Article

References (17)

1. Michowitz Y., Arbel Y., Wexler D., et al. Predictive value of high sensitivity CRP in patients with diastolic heart failure. Int J Cardiol 125 (2008) 347-351
2. Libby P. Inflammation in atherosclerosis. Nature 420 (2002) 868-874
3. Nilsson J. CRP-marker or maker of cardiovascular disease?. Arterioscler Thromb Vasc Biol 25 (2005) 1527-1528
4. Scirica B.M., and Morrow D.A. Is C-reactive protein an innocent bystander or proatherogenic culprit? The verdict is still out. Circulation 113 (2006) 2128-2134
5. Morrow D.A. C-reactive protein in cardiovascular diseases. In: Rose B.D. (Ed). UpToDate (2007) UpToDate, Wellesley
6. Tsutamoto T., Hisanaga T., Wada A., et al. Interleukin-6 spillover in the peripheral circulation increases with the severity of heart failure, and the high plasma level of interleukin-6 is an important prognostic predictor in patients with congestive heart failure. J Am Coll Cardiol 31 (1998) 391-398
7. Maeda K., Tsutamoto T., Wada A., et al. High levels of plasma brain natriuretic peptide and interleukin-6 after optimized treatment for heart failure are independent risk factors for morbidity and mortality in patients with congestive heart failure. J Am Coll Cardiol 36 (2000) 1587-1593
8. Rauchhaus M., Doehner W., Francis D.P., et al. Plasma cytokine parameters and mortality in patients with chronic heart failure. Circulation 102 (2000) 3060-3067
9. Sato Y., Takatsu Y., Kataoka K., et al. Serial circulating concentrations of C-reactive protein, interleukin (IL)-4, and IL-6 in patients with acute left heart decompensation. Clin Cardiol 22 (1999) 811-813
10. Yamauchi-Takihara K., Ihara Y., Ogata A., et al. Hypoxic stress induces cardiac myocyte-derived interleukin-6. Circulation 91 (1995) 1520-1524
11. Gabay C., and Kushner I. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 340 (1999) 448-454
12. Clark D.J., Cleman M.W., Pfau S.E., et al. Serum complement activation in congestive heart failure. Am Heart J 141 (2001) 684-690
13. Fava R.A., Gates C., and Townes A.S. Critical role of peripheral blood phagocytes and the involvement of complement in tumor necrosis factor enhancement of passive collagen-arthritis. Clin Exp Immunol 94 (1993) 261-266
14. Verma S., Wang C.H., Li S.H., et al. A self-fulfilling prophecy: C-reactive protein attenuates nitric oxide production and inhibits angiogenesis. Circulation 106 (2002) 913-919
15. Pasceri V., Willerson J.T., and Yeh E.T.H. Direct proinflammatory effect of C-reactive protein on human endothelial cells. Circulation 102 (2000) 2165-2168
16. Anand I.S., Latini R., Florea V.G., et al. C-reactive protein in heart failure: prognostic value and the effect of valsartan. Circulation 112 (2005) 1428-1434
17. Lamblin N., Mouquet F., Hennache B., et al. High-sensitivity C-reactive protein: potential adjunct for risk stratification in patients with stable congestive heart failure. Eur Heart J 26 (2005) 2245-2250